Home » Topics » BioWorld Science

BioWorld Science
RSS

Parkin, PINK keep inflammation pout of the red zone

Aug. 27, 2018

Kinase interplay prevents ALS

Aug. 27, 2018

FDA approves cobas EGFR Mutation Test v2 as companion diagnostic test with Iressa

Aug. 24, 2018

bluebird bio and Gritstone Oncology establish cancer cell therapy collaboration

Aug. 24, 2018

FDA approves Inveltys for post-operative inflammation and pain

Aug. 24, 2018

Telix submits CTA to begin phase III trial in Europe with TLX-250 for renal cancer imaging

Aug. 24, 2018

FDA approves Diacomit for seizures associated with Dravet syndrome

Aug. 24, 2018

FDA approves Takhzyro for prevention of HAE attacks

Aug. 24, 2018

DSMB completes new review of safety data from FOCUS trial of melphalan/HDS

Aug. 24, 2018

New selective Mcl-1 inhibitors with in vivo activity described by Vanderbilt University

Aug. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...